Fluidigm Licenses IP from Stanford's Quake Lab for Fetal Genetic Screening in Maternal Plasma | GenomeWeb
NEW YORK (GenomeWeb News) - Fluidigm said today that it has taken co-exclusive licenses to intellectual property developed at Stanford University for detecting fetal genetic characteristics in maternal plasma, including the use of a combination of digital PCR and high-throughput sequencing for that application.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.